Skip directly to content

Supporting Endocrine Transition (SET)

Young people with ongoing or long-term health or social care needs may be required to transition from children services into adult services. Transition, defined as a purposeful and planned process, is key to ensuring minimal disruption at a time of uncertainty for young people with health or social care needs. Improving transition services will ultimately provide better patient engagement, which in turn could lead to improvement in patient outcomes.


SET (Supporting Endocrine Transition)1 is a programme of two facilitated workshops which allows you to assess your Trusts existing transition service and conduct a GAP analysis. These learnings are then considered and inform an improvement plan for your department, supporting service development within your health economy, utilising the National Institute for Health and Care Excellence Clinical Guideline 43 (NICE CG 43).


The SET programme incorporates four separate elements:

  • A review of the NICE Transition Guideline 43
  • Assessment of your service in respect of the standards laid out within NICE CG 43
  • A GAP analysis in respect of NICE CG 43
  • Construction of an improvement plan in order to address the GAP


By requesting this MEGS you can expect to receive: 

  • Two facilitated workshops 
  • Report showing insights into your current transition service
  • Improvement plan for you to take forward within your hospital

This MEGS is available on a first come, first served basis and is dependent on capacity of the Pfizer Account Management / Medical team. This service is currently available for the following therapy areas, Endocrine and Inflammation.

Apply for Supporting Endocrine Transition (SET)



  1. NICE Guideline (NG43) Transition from children’s to adults’ services for young using health or social care, Feb 2016
PP-PFE-GBR-0643 / Sept 2017